Cargando…

Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims

Objectives To estimate the frequency and characteristics of opioid prescribing by multiple providers in Medicare and the association with hospital admissions related to opioid use. Design Retrospective cohort study. Setting Database of prescription drugs and medical claims in 20% random sample of Me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jena, Anupam B, Goldman, Dana, Weaver, Lesley, Karaca-Mandic, Pinar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928962/ https://www.ncbi.nlm.nih.gov/pubmed/24553363 http://dx.doi.org/10.1136/bmj.g1393

Ejemplares similares

Medicare and Private Insurance Variations in New Medical Technology: The Case of Drug Eluting Stents
por: Bayindir, Esra Eren, et al.
Publicado: (2016)

The opioid prescribing practices of surgeons: A comprehensive review of the 2015 claims to Medicare Part D
por: Khalid, Syed I., et al.
Publicado: (2019)

Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage
por: Everhart, Alexander, et al.
Publicado: (2021)

Characteristics of Physicians Excluded From US Medicare and State Public Insurance Programs for Fraud, Health Crimes, or Unlawful Prescribing of Controlled Substances
por: Chen, Alice, et al.
Publicado: (2018)

Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factors
por: Togun, Adeniyi T., et al.
Publicado: (2021)

Association of provider opioid prescribing practices and the Centers for Medicare and Medicaid Services hierarchical condition category score: A retrospective examination of correlation between the volume of provider-prescribed opioid medications and provider panel complexity
por: North, Frederick, et al.
Publicado: (2017)

Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration
por: Sankar, Ashwini, et al.
Publicado: (2021)

Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
por: McCoy, Rozalina G., et al.
Publicado: (2021)

Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 2016
por: Jeffery, Molly M., et al.
Publicado: (2019)

Prescribing patterns and determinants for elderly patients with Parkinson's disease in Japan: a retrospective observational study using insurance claims databases
por: Seki, Morinobu, et al.
Publicado: (2023)

Association of Formulary Exclusions and Restrictions for Opioid Alternatives With Opioid Prescribing Among Medicare Beneficiaries
por: Rao, Tanvi, et al.
Publicado: (2020)

Inappropriate prescribing of opioids for patients undergoing surgery
por: Varady, Nathan H., et al.
Publicado: (2022)

Opioid‐limiting legislation and prescribing habits of otolaryngologists among Medicare beneficiaries
por: Kim, Yun Ji, et al.
Publicado: (2023)

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study
por: Jeffery, Molly Moore, et al.
Publicado: (2018)

Changes in Surgical Opioid Prescribing and Patient-Reported Outcomes After Implementation of an Insurer Opioid Prescribing Limit
por: Chua, Kao-Ping, et al.
Publicado: (2023)

The growing problem of co-treatment with opioids and benzodiazepines
por: Karaca-Mandic, Pinar, et al.
Publicado: (2017)

Opioid prescribing patterns among medical providers in the United States, 2003-17: retrospective, observational study
por: Kiang, Mathew V, et al.
Publicado: (2020)

Early death after discharge from emergency departments: analysis of national US insurance claims data
por: Obermeyer, Ziad, et al.
Publicado: (2017)

The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims
por: Garris, Cindy, et al.
Publicado: (2015)

Physician spending and subsequent risk of malpractice claims: observational study
por: Jena, Anupam B, et al.
Publicado: (2015)

Preliminary Investigation of Pharmacist-Delivered, Direct-to-Provider Interventions to Reduce Co-Prescribing of Opioids and Benzodiazepines among a Medicare Population
por: Bingham, Jennifer M., et al.
Publicado: (2020)

Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis
por: Smoyer-Tomic, Karen E, et al.
Publicado: (2012)

The Hidden Cost of the Opioid Epidemic in the United States: Drug Screening in Insurance Claims
por: Day-Storms, Jeremy J., et al.
Publicado: (2021)

Association of 3 CDC opioid prescription guidelines for chronic pain and 2 payer pharmacy coverage changes on opioid initiation practices
por: Togun, Adeniyi T, et al.
Publicado: (2021)

Medical Claim Cost Impact of Improved Diabetes Control for Medicare and Commercially Insured Patients with Type 2 Diabetes
por: Fitch, Kathryn, et al.
Publicado: (2013)

Association between rainfall and diagnoses of joint or back pain: retrospective claims analysis
por: Jena, Anupam B, et al.
Publicado: (2017)

Provider confidence in opioid prescribing and chronic pain management: results of the Opioid Therapy Provider Survey
por: Pearson, Amy CS, et al.
Publicado: (2017)

Association Between New 340B Program Participation and Commercial Insurance Spending on Outpatient Biologic Oncology Drugs
por: Chang, Jessica, et al.
Publicado: (2023)

Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis
por: Pilon, Dominic, et al.
Publicado: (2019)

Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017
por: Mikosz, Christina A., et al.
Publicado: (2020)

Opioid-Related Diagnoses and Concurrent Claims for HIV, HBV, or HCV among Medicare Beneficiaries, United States, 2015
por: Chang, Man-Huei, et al.
Publicado: (2019)

Trends in prescribing pattern of opioid and benzodiazepine substitutes among Medicare part D beneficiaries from 2013 to 2018: a retrospective study
por: Esechie, Aimalohi, et al.
Publicado: (2021)

Republican States Bolstered Their Health Insurance Rate Review Programs Using Incentives From the Affordable Care Act
por: Fulton, Brent D., et al.
Publicado: (2015)

Comparison of SEER Treatment Data With Medicare Claims
por: Noone, Anne-Michelle, et al.
Publicado: (2016)

3377 A cross-sectional analysis of opioid prescribing patterns among gynecologic oncologists using Medicare fee-for service provider utilization & payment data
por: Samuel, David, et al.
Publicado: (2019)

Residential High-Speed Internet Among Those Likely to Benefit From an Online Health Insurance Marketplace
por: Boudreaux, Michel H., et al.
Publicado: (2016)

Costs and repeat rates associated with colonoscopy observed in medical claims for commercial and Medicare populations
por: Pyenson, Bruce, et al.
Publicado: (2014)

Prescribing trends of proton pump inhibitors, antipsychotics and benzodiazepines of medicare part d providers
por: Toth, Jennifer M., et al.
Publicado: (2022)

P137. HIGH-RISK OPIOID PRESCRIBING AND PERSISTENT OPIOID USE AFTER MAJOR LOWER LIMB AMPUTATION AMONG MEDICARE BENEFICIARIES
por: Ganesh Kumar, Nishant, et al.
Publicado: (2022)

Correction: Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis
por: Pilon, Dominic, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ilh9flisqvlkfgmdm5cl1nam73